Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
CHIESI NEW ZEALAND LIMITED,Pegunigalsidase alfa-iwxj,Fabry Disease,Pegunigalsidase alfa-iwxj (ELFABRIO),Options for investment,Community and Hospital,
